Christine Zedelmayer - 14 Feb 2025 Form 4 Insider Report for Equillium, Inc. (EQ)

Signature
/s/ Jason A. Keyes, Attorney-in-Fact
Issuer symbol
EQ
Transactions as of
14 Feb 2025
Net transactions value
$0
Form type
4
Filing time
19 Feb 2025, 19:44:59 UTC
Previous filing
06 Jan 2025
Next filing
03 Sep 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EQ Employee Stock Option (right to buy) Award +35,695 35,695 14 Feb 2025 Common Stock 35,695 $0.7850 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Disposed to Issuer -35,695 -100% 0 14 Feb 2025 Common Stock 35,695 $2.45 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Award +41,666 41,666 14 Feb 2025 Common Stock 41,666 $0.7850 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Disposed to Issuer -41,666 -100% 0 14 Feb 2025 Common Stock 41,666 $2.45 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Award +75,000 75,000 14 Feb 2025 Common Stock 75,000 $0.7850 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Disposed to Issuer -75,000 -100% 0 14 Feb 2025 Common Stock 75,000 $2.45 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Award +100,000 100,000 14 Feb 2025 Common Stock 100,000 $0.7850 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Disposed to Issuer -100,000 -100% 0 14 Feb 2025 Common Stock 100,000 $5.03 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Award +125,000 125,000 14 Feb 2025 Common Stock 125,000 $0.7850 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Disposed to Issuer -125,000 -100% 0 14 Feb 2025 Common Stock 125,000 $3.86 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Award +175,000 175,000 14 Feb 2025 Common Stock 175,000 $0.7850 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Disposed to Issuer -175,000 -100% 0 14 Feb 2025 Common Stock 175,000 $1.06 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.
F2 On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.